{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:36:11Z","timestamp":1790462171422,"version":"4.1.0"},"reference-count":237,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,11,28]],"date-time":"2005-11-28T00:00:00Z","timestamp":1133136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Ophthalmologica Scandinavica"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract.<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Intravitreal triamcinolone acetonide (IVTA) has increasingly been applied as treatment for various intraocular neovascular and oedematous diseases. Comparing the various diseases with respect to effect and side\u2010effects of the treatment, the best response in terms of gain in visual acuity (VA) has been achieved for intraretinal oedematous diseases such as diffuse diabetic macular oedema, branch retinal vein occlusion, central retinal vein occlusion and pseudophakic cystoid macular oedema. In eyes with various types of non\u2010infectious uveitis, including acute or chronic sympathetic ophthalmia and Adamantiadis\u2212Behcet's disease, VA increased and the degree of intraocular inflammation decreased. Some studies have suggested that intravitreal triamcinolone may be useful as angiostatic therapy in eyes with iris neovascularization and proliferative ischaemic retinopathies. Intravitreal triamcinolone may possibly be helpful as adjunct therapy for exudative age\u2010related macular degeneration (AMD), particularly in combination with photodynamic therapy. In eyes with chronic, therapy\u2010resistant ocular hypotony, intravitreal triamcinolone can induce an increase in intraocular pressure (IOP) and may stabilize the eye. The complications of intravitreal triamcinolone therapy include: secondary ocular hypertension in about 40% of the eyes injected; medically uncontrollable high IOP leading to antiglaucomatous surgery in about 1\u20132% of the eyes; posterior subcapsular cataract and nuclear cataract leading to cataract surgery in about 15\u201320% of elderly patients within 1\u2003year of injection; postoperative infectious endophthalmitis occurring at a rate of about one per 1000; non\u2010infectious endophthalmitis, perhaps due to a reaction to the solvent agent, and pseudo\u2010endophthalmitis with triamcinolone acetonide crystals appearing in the anterior chamber. Intravitreal triamcinolone injection can be combined with other intraocular surgeries, including cataract surgery, particularly in eyes with iris neovascularization. Cataract surgery performed some months after the injection does not show a markedly elevated complication rate. The injection may be repeated if the resultant benefits decrease after the initial IVTA injection. In non\u2010vitrectomized eyes, the duration of the effect and side\u2010effects of a single intravitreal injection of triamcinolone is about 6\u20139\u2003months for a dosage of about 20\u2003mg, and about 2\u20134\u2003months for a dosage of 4\u2003mg. So far, it has remained unclear whether the solvent agent should be removed, and if so, how.<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1111\/j.1600-0420.2005.00592.x","type":"journal-article","created":{"date-parts":[[2005,11,28]],"date-time":"2005-11-28T05:24:09Z","timestamp":1133155449000},"page":"645-663","source":"Crossref","is-referenced-by-count":98,"title":["Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases"],"prefix":"10.1111","volume":"83","author":[{"given":"Jost B.","family":"Jonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11,28]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.05.031"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200410001-00002"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.01.032"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200302000-00022"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2003.08.035"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00658-8"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01681698"},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-005-1177-y"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-1110"},{"key":"e_1_2_15_11_1","doi-asserted-by":"crossref","unstructured":"AugustinAJ&Schmidt\u2010ErfuhrtU(2005a):Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularisation due to age\u2010related macular degeneration. Ophthalmology In Press.","DOI":"10.1016\/j.ophtha.2005.09.002"},{"key":"e_1_2_15_12_1","unstructured":"AugustinAJ&Schmidt\u2010ErfuhrtU(2005b):Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult chorodidal neovascularisation in age\u2010related macular degeneration. Am J Ophthalmol In Press."},{"key":"e_1_2_15_13_1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3928\/1542-8877-20030901-08","article-title":"The effect of intravitreal triamcinolone acetonide on intraocular pressure","volume":"34","author":"Bakri SJ","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-4182(04)80069-3"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.09.038"},{"key":"e_1_2_15_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701602"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-004-0911-1"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/08820530390895262"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.8.1137"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1966.03850010479003"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01969-3"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01938-4"},{"key":"e_1_2_15_23_1","first-page":"661","article-title":"[Intravitreal injection of triamcinolone acetonide in non\u2010infectious uveitis.]","volume":"76","author":"Benitez Del Castillo Sanchez JM","year":"2001","journal-title":"Arch Soc Esp Oftalmol"},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.2.271"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1984.01040030470029"},{"key":"e_1_2_15_26_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/112067210501500114","article-title":"Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular oedema: functional and anatomic results","volume":"15","author":"Boscia F","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(02)00338-7"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.12.1801"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.5.649"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200504000-00003"},{"key":"e_1_2_15_31_1","first-page":"1048","article-title":"[Intraocular pressure elevation after sub\u2010Tenon injection of triamcinolone acetonide during uveitis.]","volume":"25","author":"Bui Quoc E","year":"2002","journal-title":"J Fr Ophtalmol"},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(03)00016-6"},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)02030-5"},{"key":"e_1_2_15_34_1","first-page":"704","article-title":"Triamcinolone stimulates bFGF production and inhibits TGF\u2010beta\u20101 production by human dermal fibroblasts","volume":"28","author":"Carroll LA","year":"2002","journal-title":"Dermatol Surg"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(95)30849-4"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.1998.tb01330.x"},{"key":"e_1_2_15_37_1","first-page":"625\u2212630","article-title":"Ocular\u2010hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6\u2010month follow\u2010up study","volume":"19","author":"Chan CK","year":"2004","journal-title":"Eye"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02150144"},{"key":"e_1_2_15_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.88.1.154"},{"key":"e_1_2_15_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.033589"},{"key":"e_1_2_15_41_1","first-page":"2160","article-title":"The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy","volume":"33","author":"Chen EP","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_15_42_1","article-title":"Intravi\u2010treal triamcinolone staining observation of residual undetached cortical vitreous after posterior vitreous detachment","author":"Chen TY","year":"2005","journal-title":"Eye In Press"},{"key":"e_1_2_15_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.041707"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.8.1032"},{"key":"e_1_2_15_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.3.399"},{"key":"e_1_2_15_46_1","first-page":"890","article-title":"Treatment of pseudophatic cystoid macular edema by elevation of intraocular pressure","volume":"16","author":"Civerchia LL","year":"1984","journal-title":"Ann Ophthalmol"},{"key":"e_1_2_15_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-199212010-00010"},{"key":"e_1_2_15_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(02)01441-4"},{"key":"e_1_2_15_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30383-7"},{"key":"e_1_2_15_50_1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","article-title":"Intravitreal triamcinolone acetonide in exudative age\u2010related macular degeneration","volume":"20","author":"Danis RP","year":"2000","journal-title":"Retina"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.3.361"},{"key":"e_1_2_15_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.01.008"},{"key":"e_1_2_15_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00506.x"},{"key":"e_1_2_15_54_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2003.00084.x"},{"key":"e_1_2_15_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-003-0862-7"},{"key":"e_1_2_15_56_1","first-page":"45","article-title":"Refractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonide","volume":"292","author":"Detry\u2010Morel M","year":"2004","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"e_1_2_15_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2004.09.013"},{"key":"e_1_2_15_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01917-7"},{"key":"e_1_2_15_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198709000-00016"},{"key":"e_1_2_15_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200312000-00004"},{"key":"e_1_2_15_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2003.09.027"},{"key":"e_1_2_15_62_1","first-page":"818\u2212820","article-title":"Intravitreal triamcinolone for macular detachment following panretinal photocoagulation","volume":"19","author":"Gharbiya M","year":"2004","journal-title":"Eye"},{"key":"e_1_2_15_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-199515040-00005"},{"key":"e_1_2_15_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.07.017"},{"key":"e_1_2_15_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.3.336"},{"key":"e_1_2_15_66_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.5.667"},{"key":"e_1_2_15_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1974.01010010155016"},{"key":"e_1_2_15_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.2.247"},{"key":"e_1_2_15_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01743-8"},{"key":"e_1_2_15_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.09.024"},{"key":"e_1_2_15_71_1","doi-asserted-by":"publisher","DOI":"10.1159\/000068980"},{"key":"e_1_2_15_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00920049"},{"key":"e_1_2_15_73_1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3928\/1542-8877-20040701-18","article-title":"A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection","volume":"35","author":"Hernaez\u2010Ortega MC","year":"2004","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"e_1_2_15_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(86)90593-3"},{"key":"e_1_2_15_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00379.x"},{"key":"e_1_2_15_76_1","first-page":"92","article-title":"[Intravitreal injection of triamcinolone acetonide for cystoid macular oedema resistant to vitreous surgery.]","volume":"108","author":"Inoue M","year":"2004","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"e_1_2_15_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.8.1131"},{"key":"e_1_2_15_78_1","doi-asserted-by":"publisher","DOI":"10.1076\/soph.18.2.67.15860"},{"key":"e_1_2_15_79_1","first-page":"1217","article-title":"Intravitreous triamcinolone acetonide as treatment for macular oedema from central retinal vein occlusion","volume":"120","author":"Ip MS","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_15_80_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1985.01050050100026"},{"key":"e_1_2_15_81_1","first-page":"65\u221271","article-title":"Improved visual acuity and macular thickness 1\u2003week after intravitreal triamcinolone for diabetic macular oedema","volume":"19","author":"Islam MS","year":"2004","journal-title":"Eye"},{"key":"e_1_2_15_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-003-0975-z"},{"key":"e_1_2_15_83_1","article-title":"Resolution of severe macular oedema in adult Coat's syndrome with high\u2010dose intravitreal triamcinolone acetonide","author":"Jarin RR","year":"2005","journal-title":"Eye 11 February 2005 [Epub ahead of print]"},{"key":"e_1_2_15_84_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.9.1064"},{"key":"e_1_2_15_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)01010-8"},{"key":"e_1_2_15_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00882-5"},{"key":"e_1_2_15_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200108000-00007"},{"key":"e_1_2_15_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004170100293"},{"key":"e_1_2_15_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(02)01295-6"},{"key":"e_1_2_15_90_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.12.1450-a"},{"key":"e_1_2_15_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-002-0529-0"},{"key":"e_1_2_15_92_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.9.1066"},{"key":"e_1_2_15_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-002-0547-y"},{"key":"e_1_2_15_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-003-0719-4"},{"key":"e_1_2_15_95_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1395-3907.2003.0108.x"},{"key":"e_1_2_15_96_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210301300508"},{"key":"e_1_2_15_97_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.4.462"},{"key":"e_1_2_15_98_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.1.57"},{"key":"e_1_2_15_99_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2003.00130.x"},{"key":"e_1_2_15_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00230-7"},{"key":"e_1_2_15_101_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210301300611"},{"key":"e_1_2_15_102_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.1.24"},{"key":"e_1_2_15_103_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.5.729"},{"key":"e_1_2_15_104_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.11.1663-b"},{"key":"e_1_2_15_105_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.034140"},{"key":"e_1_2_15_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00899-7"},{"key":"e_1_2_15_107_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.2.218"},{"key":"e_1_2_15_108_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.028688"},{"key":"e_1_2_15_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.02.025"},{"key":"e_1_2_15_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2003.08.012"},{"key":"e_1_2_15_111_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.039552"},{"key":"e_1_2_15_112_1","first-page":"65\u221271","article-title":"Intravitreal triamcinolone acetonide as treatment of branch retinal vein occlusion","volume":"19","author":"Jonas JB","year":"2004","journal-title":"Eye"},{"key":"e_1_2_15_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.07.007"},{"key":"e_1_2_15_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-003-0841-3"},{"key":"e_1_2_15_115_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700654"},{"key":"e_1_2_15_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.06.041"},{"key":"e_1_2_15_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200406000-00016"},{"key":"e_1_2_15_118_1","article-title":"Intravitreal triamcinolone acetonide for persisting cystoid macular oedema after penetrating keratoplasty","author":"Jonas JB","year":"2005","journal-title":"Cornea In Press"},{"key":"e_1_2_15_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701438"},{"key":"e_1_2_15_120_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.054247"},{"key":"e_1_2_15_121_1","article-title":"Five\u2010fold intravitreal re\u2010injection of high\u2010dose triamcinolone acetonide for exudative age\u2010related macular degeneration","author":"Jonas JB","year":"2005","journal-title":"Indian J Ophthalmol In Press"},{"key":"e_1_2_15_122_1","article-title":"Foveal telangiectasia treated by intravitreal triamcinolone acetonide","author":"Jonas JB","year":"2005","journal-title":"Indian J Ophthalmol In Press"},{"key":"e_1_2_15_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.01.032"},{"key":"e_1_2_15_124_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.10.1338"},{"key":"e_1_2_15_125_1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/112067210501500407","article-title":"Frequency of cataract surgery after intravitreal injection of high\u2010dosage triamcinolone acetonide","volume":"15","author":"Jonas JB","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_15_126_1","article-title":"Intravitreal triamcinolone acetonide as treatment of central retinal vein occlusion","author":"Jonas JB","year":"2005","journal-title":"Eur J Ophthalmol In Press"},{"key":"e_1_2_15_127_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.050575"},{"key":"e_1_2_15_128_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.046391"},{"key":"e_1_2_15_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.10.042"},{"key":"e_1_2_15_130_1","article-title":"Retinal pigment epithelium detachment treated by intravitreal triamcinolone acetonide","author":"Jonas JB","year":"2005","journal-title":"Ophthalmic Surg, Lasers Imaging In Press"},{"key":"e_1_2_15_131_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1395-3907.2003.0146.x"},{"key":"e_1_2_15_132_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:INTE.0000031740.85124.78"},{"key":"e_1_2_15_133_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200404000-00030"},{"key":"e_1_2_15_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.02.053"},{"key":"e_1_2_15_135_1","first-page":"754\u2212757","article-title":"Does intravitreal triamcinolone acetonide\u2010assisted peeling of the internal limiting membrane effect the outcome of macular hole surgery?","volume":"243","author":"Karacorlu M","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol 2005;"},{"key":"e_1_2_15_136_1","first-page":"382\u2212386","article-title":"Intravitreal triamcinolone as a primary therapy in diabetic macular oedema","volume":"19","author":"Karacorlu M","year":"2006","journal-title":"Eye"},{"key":"e_1_2_15_137_1","first-page":"758","article-title":"Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion","volume":"137","author":"Kaushik S","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_15_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00782-7"},{"key":"e_1_2_15_139_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200406000-00022"},{"key":"e_1_2_15_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.04.064"},{"key":"e_1_2_15_141_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-004-1059-8"},{"key":"e_1_2_15_142_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00400.x"},{"key":"e_1_2_15_143_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00490.x"},{"key":"e_1_2_15_144_1","first-page":"605\u2212608","article-title":"Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation under intraconical anaesthesia for proliferative retinopathy with high\u2010risk characteristics for severe visual loss and cystoid macular oedema in an adolescent patient with type 1 diabetes","volume":"83","author":"Kyt\u00f6 JP","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"issue":"6","key":"e_1_2_15_145_1","first-page":"1100","article-title":"Sequential treatment of central retinal vein occlusion with intravitreal tissue plasminogen activator and intravitreal triamcinolone","volume":"88","author":"Lahey JM","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"e_1_2_15_146_1","first-page":"382\u2212386","article-title":"Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6\u2010month prospective pilot study","volume":"19","author":"Lam DS","year":"2004","journal-title":"Eye"},{"key":"e_1_2_15_147_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2004.00903.x"},{"key":"e_1_2_15_148_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00440.x"},{"key":"e_1_2_15_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.12.054"},{"key":"e_1_2_15_150_1","doi-asserted-by":"publisher","DOI":"10.1080\/08820530490885884"},{"key":"e_1_2_15_151_1","first-page":"692","article-title":"Intravitreal triamcinolone injection for macular oedema secondary to increased retinal vascular permeability","volume":"103","author":"Lee WF","year":"2004","journal-title":"J Formos Med Assoc"},{"key":"e_1_2_15_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-4182(04)80035-8"},{"key":"e_1_2_15_153_1","first-page":"1771","article-title":"Proliferative vitreoretinopathy, PVR. A personal account of its pathogenesis and treatment. Proctor lecture","volume":"29","author":"Machemer R","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_15_154_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-199616020-00017"},{"key":"e_1_2_15_155_1","first-page":"171","article-title":"Treatment of intraocular proliferations with intravitreal steroids","volume":"77","author":"Machemer R","year":"1979","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_2_15_156_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm010511b"},{"key":"e_1_2_15_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)00975-2"},{"key":"e_1_2_15_158_1","first-page":"1380","article-title":"Intravitreal triamcinolone for refractory cystoid macular oedema secondary to birdshot retinochoroidopathy","volume":"119","author":"Martidis A","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_15_159_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.11.1658"},{"key":"e_1_2_15_160_1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/112067210401400624","article-title":"Intravitreal triamcinolone in cystoid macular oedema due to uveitis and repeated surgery after a penetrating trauma","volume":"14","author":"Marullo M","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_15_161_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200412000-00009"},{"key":"e_1_2_15_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.05.037"},{"key":"e_1_2_15_163_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200308000-00028"},{"key":"e_1_2_15_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(81)90013-1"},{"key":"e_1_2_15_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(93)31675-1"},{"key":"e_1_2_15_166_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/112067210401400407","article-title":"Intravitreal triamcinolone acetonide: valuation of retinal thickness changes measured by optical coherence tomography in diffuse diabetic macular oedema","volume":"14","author":"Micelli Ferrari","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_15_167_1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3928\/1542-8877-19981101-12","article-title":"Accidental subretinal injection of triamcinolone acetonide","volume":"29","author":"Modarres M","year":"1998","journal-title":"Ophthalmic Surg Lasers"},{"key":"e_1_2_15_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00483-5"},{"key":"e_1_2_15_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01426-5"},{"key":"e_1_2_15_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.03.025"},{"key":"e_1_2_15_171_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700457"},{"key":"e_1_2_15_172_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701636"},{"key":"e_1_2_15_173_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200310000-00014"},{"key":"e_1_2_15_174_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200312000-00005"},{"key":"e_1_2_15_175_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.8.968"},{"key":"e_1_2_15_176_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-005-1125-x"},{"key":"e_1_2_15_177_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-004-1064-y"},{"key":"e_1_2_15_178_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00395.x"},{"key":"e_1_2_15_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-4182(05)80119-X"},{"key":"e_1_2_15_180_1","article-title":"Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion","author":"Ozkiris A","year":"2005","journal-title":"Eye In Press"},{"key":"e_1_2_15_181_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/112067210501500115","article-title":"The efficacy of intravitreal triamcinolone acetonide on macular oedema in branch retinal vein occlusion","volume":"15","author":"Ozkiris A","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_15_182_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210401400615"},{"key":"e_1_2_15_183_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-004-2956-1"},{"key":"e_1_2_15_184_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.6.897"},{"key":"e_1_2_15_185_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00228-9"},{"key":"e_1_2_15_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2003.08.051"},{"key":"e_1_2_15_187_1","first-page":"711\u2212713","article-title":"Intravitreal triamcinolone acetonide in Eales' disease: a case report","volume":"19","author":"Pathengay A","year":"2004","journal-title":"Eye"},{"key":"e_1_2_15_188_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200504000-00024"},{"key":"e_1_2_15_189_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.6.600"},{"key":"e_1_2_15_190_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.5.527"},{"key":"e_1_2_15_191_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.1995.tb00179.x"},{"key":"e_1_2_15_192_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01316.x"},{"key":"e_1_2_15_193_1","first-page":"3125","article-title":"Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells","volume":"43","author":"Penfold PL","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_15_194_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-9071.2001.00407.x"},{"key":"e_1_2_15_195_1","first-page":"283","article-title":"The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity","volume":"42","author":"Penn JS","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_15_196_1","first-page":"43","article-title":"Treatment of Graves' macular oedema with intravitreal injection of corticosteroids","volume":"288","author":"Rakic JM","year":"2003","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"e_1_2_15_197_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.5.527"},{"key":"e_1_2_15_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00389-1"},{"key":"e_1_2_15_199_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.027177"},{"key":"e_1_2_15_200_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2002.tb00134.x"},{"key":"e_1_2_15_201_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210301300309"},{"key":"e_1_2_15_202_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.7.1085"},{"key":"e_1_2_15_203_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.9.1279"},{"key":"e_1_2_15_204_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-002-0454-2"},{"key":"e_1_2_15_205_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-0067-4_10"},{"key":"e_1_2_15_206_1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3928\/1542-8877-20030901-11","article-title":"Treatment of cystoid macular oedema related to retinitis pigmentosa with intravitreal triamcinolone acetonide","volume":"34","author":"Saraiva VS","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"e_1_2_15_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(82)90130-1"},{"key":"e_1_2_15_208_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1985.01050100143037"},{"key":"e_1_2_15_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00266-6"},{"key":"e_1_2_15_210_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.4.581"},{"key":"e_1_2_15_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.03.001"},{"key":"e_1_2_15_212_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.06.067"},{"key":"e_1_2_15_213_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.05.073"},{"key":"e_1_2_15_214_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.8.1010"},{"key":"e_1_2_15_215_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2004.00336.x"},{"key":"e_1_2_15_216_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200504000-00007"},{"key":"e_1_2_15_217_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00544-X"},{"key":"e_1_2_15_218_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.09.059"},{"key":"e_1_2_15_219_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.052563"},{"key":"e_1_2_15_220_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.10.1491"},{"key":"e_1_2_15_221_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.8.972"},{"key":"e_1_2_15_222_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.05.025"},{"key":"e_1_2_15_223_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00674-3"},{"key":"e_1_2_15_224_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)75196-7"},{"key":"e_1_2_15_225_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(80)90239-1"},{"key":"e_1_2_15_226_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2004.00224.x"},{"key":"e_1_2_15_227_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-001-0398-y"},{"key":"e_1_2_15_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.01.001"},{"key":"e_1_2_15_229_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1992.01080200135041"},{"key":"e_1_2_15_230_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1606.1999.00238.x"},{"key":"e_1_2_15_231_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.05.033"},{"key":"e_1_2_15_232_1","doi-asserted-by":"publisher","DOI":"10.1159\/000078615"},{"key":"e_1_2_15_233_1","doi-asserted-by":"publisher","DOI":"10.1159\/000079470"},{"key":"e_1_2_15_234_1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3928\/15428877-20050101-04","article-title":"Early treatment of cystoid macular oedema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide","volume":"36","author":"Yepremyan M","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"e_1_2_15_235_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-003-0053-8"},{"key":"e_1_2_15_236_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0490"},{"key":"e_1_2_15_237_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-9071.2001.00360.x"},{"key":"e_1_2_15_238_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200502000-00003"}],"container-title":["Acta Ophthalmologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0420.2005.00592.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0420.2005.00592.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T20:32:14Z","timestamp":1696969934000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0420.2005.00592.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,28]]},"references-count":237,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1600-0420.2005.00592.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0420.2005.00592.x","archive":["Portico"],"relation":{},"ISSN":["1395-3907","1600-0420"],"issn-type":[{"value":"1395-3907","type":"print"},{"value":"1600-0420","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,28]]}}}